BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6455233)

  • 1. Diffusely increased Tc-99m-MDP uptake in both kidneys.
    Koizumi K; Tonami N; Hisada K
    Clin Nucl Med; 1981 Aug; 6(8):362-5. PubMed ID: 6455233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of diffusely increased 99mTc phosphonate compounds uptake in both kidneys].
    Tonami N; Koizumi K; Hisada K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Jun; 42(6):576-81. PubMed ID: 7145618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Uptake of 99mTc-MDP by the lung and liver].
    Ohchida T; Ichiya A; Matsuura K; Ooiwa T
    Rinsho Hoshasen; 1984 Mar; 29(3):437-8. PubMed ID: 6235386
    [No Abstract]   [Full Text] [Related]  

  • 4. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High renal activity on bone scintigrams. A sign of hypercalcaemia?
    Buxton-Thomas MS; Wraight EP
    Br J Radiol; 1983 Dec; 56(672):911-4. PubMed ID: 6228281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local findings of renal cell carcinoma on 99m-Tc-DMSA renal, 99m-Tc-MDP bone and 67-Ga-citrate scintigraphies].
    Kawamura J; Itoh H; Yoshida O; Fujita T; Fukunaga M; Morita R; Torizuka K
    Kaku Igaku; 1982 Apr; 19(3):357-68. PubMed ID: 6290720
    [No Abstract]   [Full Text] [Related]  

  • 7. Transient accumulation of Tc 99m MDP in the liver.
    Dudczak R; Angelberger P; Kletter K; Frischauf H
    Eur J Nucl Med; 1980 Apr; 5(2):189-91. PubMed ID: 6445828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B therapy: a cause of increased renal uptake of Tc-99m MDP.
    Trackler RT; Chinn RY
    Clin Nucl Med; 1982 Jun; 7(6):293. PubMed ID: 6211323
    [No Abstract]   [Full Text] [Related]  

  • 9. A crossover study comparing Tc-99m-labeled HMDP and MDP in patients.
    Rosenthall L; Arzoumanian A; Damtew BU; Tremblay J
    Clin Nucl Med; 1981 Aug; 6(8):353-5. PubMed ID: 6455231
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased uptake of technetium-99m-labeled bone imaging agents in the kidneys.
    Siddiqui AR
    Semin Nucl Med; 1982 Jan; 12(1):101-2. PubMed ID: 6210961
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical observation of diffuse renal accumulation of 99mTc-MDP].
    Takeji H; Sui O; Shimazu H; Watanabe N; Kawaguchi K; Kawahara Y; Komatsu Y; Yoshida S
    Rinsho Hoshasen; 1984 Aug; 29(8):875-9. PubMed ID: 6210380
    [No Abstract]   [Full Text] [Related]  

  • 12. Tc-99m MDP bone scan artefact. Abdominal soft tissue uptake secondary to subcutaneous heparin injection.
    Duong RB; Volarich DT; Fernandez-Ulloa M; Vasavada PJ
    Clin Nucl Med; 1984 Jan; 9(1):47. PubMed ID: 6230190
    [No Abstract]   [Full Text] [Related]  

  • 13. [Extraosseous accumulation of 99m-Tc-MDP--with special reference to intratumor accumulation].
    Yasuda E; Yoshida H; Ichikawa H; Matsuo S; Kimura T; Kanamori I; Nakano S; Watahiki H; Takeda I
    Rinsho Hoshasen; 1983 Aug; 28(8):851-7. PubMed ID: 6228679
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased renal uptake of [99mTc]methylene diphosphonate.
    Lin DS; Sanders JA; Flowers WM
    Int J Nucl Med Biol; 1982; 9(3):201-7. PubMed ID: 6215374
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R; Neumann R; Goldsmith SJ
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
    Littlefield JL; Rudd TG
    J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pleural effusion and Tc-99m MDP accumulation.
    Lamki L; Cohen P; Driedger A
    Clin Nucl Med; 1982 Jul; 7(7):331-3. PubMed ID: 6212180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult gastric bleeding demonstrated by bone scan and Tc-99m-DTPA renal scan.
    Lee VW; Leiter BE; Weitzman F; Shapiro JH
    Clin Nucl Med; 1981 Oct; 6(10):470-3. PubMed ID: 6457714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.